The over-activation of the MR in patients with DN causes metabolic disorders, including hypokalemia and sodium and water retention, and mediates the onset and progression of tissue inflammation and fibrosis of kidneys and hearts, which further leads to a variety of adverse renal and cardiac outcomes [9]. Here, NR3C2 is linked to liver dysplastic nodule.